The DOI matches its Crossref record; 208 of the 208 references it cites were found in a registry or an index.
Review: Systemic inflammation andAlzheimer's disease
Abstract
There is a great deal of evidence suggesting an important role for systemic inflammation in the pathogenesis of A lzheimer's disease. The role of systemic inflammation, and indeed inflammation in general, is still largely considered to be as a contributor to the disease process rather than of aetiological importance although there is emerging evidence to suggest that its role may predate the deposition of amyloid. Therapies aimed at reducing inflammation in individuals with mild cognitive impairment and A lzheimer's disease have been disappointing and have largely focused on the need to ameliorate central inflammation with little attention to the importance of dampening down systemic inflammation. Novel approaches in this area require a greater understanding of the effects of systemic inflammation on the development and progression of A lzheimer's disease and of the communicating pathways between the systemic and central innate immune systems.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Although the genetic susceptibility, numerous findings support the involvement in AD pathogenesis of other mechanisms such as inflammation [95], imbalance among production and removal of ROS [96], mitochondrial dysfunction [82], in addition to the β-amyloid cascade [97] and the deficiency of central cholinergic neurotransmitters [98] on which are based most of anti-AD drugs so far approved.”
From Treatment of Alzheimer’s Disease: Beyond Symptomatic Therapies (2023) · cites this paper as [95]
In the citing paper
“Crosstalk between systemic and central innate immune systems by the release of inflammatory mediators is observed in AD (Holmes, 2013).”
From The impact of microglial activation on blood-brain barrier in brain diseases (2014) · cites this paper as Holmes, 2013
Citations
Cites
Items 201–208 of 208
Is TNF a Link between Aging-Related Reproductive Endocrine Dyscrasia and Alzheimer's Disease?
Clark, I. A., & Atwood, C. (2011) · Journal of Alzheimer s Disease · doi:10.3233/jad-2011-110887 · Cited by 19
Herpes simplex virus tipo 1 como factor de riesgo asociado con la enfermedad de Alzheimer
Martín, C., Solís, L., Concha, M. I., & Carola Otth, L. (2011) · Revista médica de Chile · doi:10.4067/s0034-98872011000600013 · Cited by 11
Inflammatory Proteins in Plasma and the Risk of Dementia: The Rotterdam Study
Engelhart, M. J., Geerlings, M. I., Meijer, J., Kiliaan, A., Ruitenberg, A., van Swieten, J. C., Stijnen, T., Hofman, A., Witteman, J. C. M., & Breteler, M. M. B. (2004) · Archives of Neurology · doi:10.1001/archneur.61.5.668 · Cited by 10
Gastric Mucosal Cell Cycle Regulation with Ulcer Healing by Sulglycotide
Slomiany, B. L., Piotrowski, J., & Slomiany, A. (1997) · Scandinavian Journal of Gastroenterology · doi:10.3109/00365529709011194 · Cited by 10
Stankovic, G. R., & Sparks, D. L. (2006) · Neurological Research · doi:10.1179/016164106x130452 · Cited by 9
Effects of indomethacin on secretory function of synoviocytes from adjuvant arthritis rats.
Wang, B., & Mz, C. (1998) · PubMed · Cited by 9
Aisen, P. S., Schafer, K. A., Grundman, M., Pfeiffer, E., Sano, M., Davis, K. L., Farlow, M. R., Jin, S., Thomas, R. G., Thal, L. J., et al. (2003) · JAMA · doi:10.1001/jama.289.21.2819 · Cited by 5
Cann, S. A. H., Netten, J. P. V., & Netten, C. V. (2000) · Pure Amsterdam UMC · doi:10.1002/1531-8249(200003)47:3
Flagged first, then by citations
Research works printed but not linked: 1
- Bohac D, 2002, A 24‐week randomized, double‐blind, placebo‐controlled study of the efficacy and tolerability of TNFR: Fc (etanercept) in the treatment of dementia of the Alzheimer type, Neurobiol Aging, 23, 315
Cited by
Sorted by citations
The impact of microglial activation on blood-brain barrier in brain diseases
da Fonseca, A. C. C., Matias, D., Garcia, C., Amaral, R., Geraldo, L. H., Freitas, C., & Lima, F. R. S. (2014) · Frontiers in Cellular Neuroscience · doi:10.3389/fncel.2014.00362 · Cited by 572
Chen, S. G., Stribinskis, V., Rane, M. J., Demuth, D. R., Gozal, E., Roberts, A. M., Jagadapillai, R., Liu, R., Choe, K., Shivakumar, B., et al. (2016) · Scientific Reports · doi:10.1038/srep34477 · Cited by 463
TLR4 Cross-Talk With NLRP3 Inflammasome and Complement Signaling Pathways in Alzheimer's Disease
Yang, J., Wise, L., & Fukuchi, K.-I. (2020) · Frontiers in Immunology · doi:10.3389/fimmu.2020.00724 · Cited by 387
Mechanisms of Molecular Mimicry Involving the Microbiota in Neurodegeneration
Friedland, R. P. (2015) · Journal of Alzheimer's Disease · doi:10.3233/jad-142841 · Cited by 338
The dual roles of cytokines in Alzheimer’s disease: update on interleukins, TNF-α, TGF-β and IFN-γ
Zheng, C., Zhou, X.-W., & Wang, J.-Z. (2016) · Translational Neurodegeneration · doi:10.1186/s40035-016-0054-4 · Cited by 292
Metadata
- Authors
- Holmes, C.
- Affiliations
- Moorgreen Hospital (GB)
- Corresponding author
- Holmes, C.
- ORCID
- Holmes, C.
- Venue
- Neuropathology and Applied Neurobiology
- Publisher
- Wiley
- Published
- 2013-01-22
- Volume
- 39
- Issue
- 1
- Pages
- 51-68
- ISSN
- 0305-1846 (ISSN-L)
- 1365-2990
- OpenAlex
- W1916976076
- Semantic Scholar
- 22fc4893fe1c0cf60f5834083c9fe4f5159933fd
- Cited by
- 356
- References
- 208
- Citations by year
- 2026: 17 · 2025: 12 · 2024: 29 · 2023: 52 · 2022: 48 · 2021: 33 · 2020: 38 · 2019: 32 · 2018: 23 · 2017: 24 · 2016: 15 · 2015: 16 · 2014: 11 · 2013: 4
- FWCI
- 0.95
- Type
- journal article
- Language
- en
- Open access
- closed
- Locations
- Neuropathology and Applied Neurobiology (publishedVersion)
- PubMed (publishedVersion)
- Funders
- Alzheimer Society
- Topics
- Life Sciences › Neuroscience › Neurology › Neuroinflammation and Neurodegeneration Mechanisms
- Life Sciences › Neuroscience › Cellular and Molecular Neuroscience › Alzheimer's disease research and treatments
- Health Sciences › Medicine › Psychiatry and Mental health › Dementia and Cognitive Impairment Research
- Keywords
- systemic inflammation, Alzheimer's disease, pathogenesis, amyloid deposition, mild cognitive impairment, anti-inflammatory therapy, innate immune system, neuroinflammation
- MeSH terms
- Alzheimer Disease, Animals, Humans, Inflammation
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
